Cargando…
Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
BACKGROUND: Prevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10–14 is a universal fam...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902023/ https://www.ncbi.nlm.nih.gov/pubmed/24438460 http://dx.doi.org/10.1186/1471-2458-14-49 |
_version_ | 1782300940804554752 |
---|---|
author | Segrott, Jeremy Gillespie, David Holliday, Jo Humphreys, Ioan Murphy, Simon Phillips, Ceri Reed, Hayley Rothwell, Heather Foxcroft, David Hood, Kerenza Roberts, Zoe Scourfield, Jonathan Thomas, Claire Moore, Laurence |
author_facet | Segrott, Jeremy Gillespie, David Holliday, Jo Humphreys, Ioan Murphy, Simon Phillips, Ceri Reed, Hayley Rothwell, Heather Foxcroft, David Hood, Kerenza Roberts, Zoe Scourfield, Jonathan Thomas, Claire Moore, Laurence |
author_sort | Segrott, Jeremy |
collection | PubMed |
description | BACKGROUND: Prevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10–14 is a universal family-based alcohol, drugs and tobacco prevention programme, which has achieved promising results in US trials, and which now requires cross-cultural assessment. This paper therefore describes the protocol for a randomised controlled trial of the UK version of the Strengthening Families Programme 10–14 (SFP 10–14 UK). METHODS/DESIGN: The trial comprises a pragmatic cluster randomised controlled effectiveness trial with families as the unit of randomisation, with embedded process and economic evaluations. Participating families will be randomised to one of two treatment groups - usual care with full access to existing services (control group), or usual care plus SFP 10–14 UK (intervention group). The trial has two primary outcomes - the number of occasions that young people report having drunk alcohol in the last 30 days, and drunkenness during the last 30 days, both dichotomised as ‘never’ and ‘1-2 times or more’. The main follow-up is at 2 years past baseline, and short-term and intermediate outcomes are also measured at 9 and 15 months. DISCUSSION: The results from this trial will provide evidence on the effectiveness and cost-effectiveness of an innovative universal family-based substance misuse prevention programme in a UK context. TRIAL REGISTRATION: Current Controlled Trials ISRCTN63550893. |
format | Online Article Text |
id | pubmed-3902023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39020232014-01-26 Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) Segrott, Jeremy Gillespie, David Holliday, Jo Humphreys, Ioan Murphy, Simon Phillips, Ceri Reed, Hayley Rothwell, Heather Foxcroft, David Hood, Kerenza Roberts, Zoe Scourfield, Jonathan Thomas, Claire Moore, Laurence BMC Public Health Study Protocol BACKGROUND: Prevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10–14 is a universal family-based alcohol, drugs and tobacco prevention programme, which has achieved promising results in US trials, and which now requires cross-cultural assessment. This paper therefore describes the protocol for a randomised controlled trial of the UK version of the Strengthening Families Programme 10–14 (SFP 10–14 UK). METHODS/DESIGN: The trial comprises a pragmatic cluster randomised controlled effectiveness trial with families as the unit of randomisation, with embedded process and economic evaluations. Participating families will be randomised to one of two treatment groups - usual care with full access to existing services (control group), or usual care plus SFP 10–14 UK (intervention group). The trial has two primary outcomes - the number of occasions that young people report having drunk alcohol in the last 30 days, and drunkenness during the last 30 days, both dichotomised as ‘never’ and ‘1-2 times or more’. The main follow-up is at 2 years past baseline, and short-term and intermediate outcomes are also measured at 9 and 15 months. DISCUSSION: The results from this trial will provide evidence on the effectiveness and cost-effectiveness of an innovative universal family-based substance misuse prevention programme in a UK context. TRIAL REGISTRATION: Current Controlled Trials ISRCTN63550893. BioMed Central 2014-01-17 /pmc/articles/PMC3902023/ /pubmed/24438460 http://dx.doi.org/10.1186/1471-2458-14-49 Text en Copyright © 2014 Segrott et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Segrott, Jeremy Gillespie, David Holliday, Jo Humphreys, Ioan Murphy, Simon Phillips, Ceri Reed, Hayley Rothwell, Heather Foxcroft, David Hood, Kerenza Roberts, Zoe Scourfield, Jonathan Thomas, Claire Moore, Laurence Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) |
title | Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) |
title_full | Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) |
title_fullStr | Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) |
title_full_unstemmed | Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) |
title_short | Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) |
title_sort | preventing substance misuse: study protocol for a randomised controlled trial of the strengthening families programme 10–14 uk (sfp 10–14 uk) |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902023/ https://www.ncbi.nlm.nih.gov/pubmed/24438460 http://dx.doi.org/10.1186/1471-2458-14-49 |
work_keys_str_mv | AT segrottjeremy preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT gillespiedavid preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT hollidayjo preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT humphreysioan preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT murphysimon preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT phillipsceri preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT reedhayley preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT rothwellheather preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT foxcroftdavid preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT hoodkerenza preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT robertszoe preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT scourfieldjonathan preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT thomasclaire preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk AT moorelaurence preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk |